Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Theranostics
|
July 21, 2018
Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins
Rachel Blau, Yana Epshtein, Evgeni Pisarevsky, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 2, 2018
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma
Galia Tiram, Shiran Ferber, Paula Ofek, et al.
JAMA Oncology
|
February 3, 2018
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial
Martin J B Taphoorn, Linda Dirven, Andrew A Kanner, et al.
JAMA
|
December 21, 2017
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew Kanner, et al.
Molecular Cancer
|
August 10, 2023
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial
Eelke M Bos, Elena Binda, Iris S C Verploegh, et al.
JAMA
|
December 17, 2015
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew A Kanner, et al.
Acta Neuropathologica
|
May 10, 2019
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
Nagarajan Paramasivam, Daniel Hübschmann, Umut H Toprak, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2012
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality
Roger Stupp, Eric T Wong, Andrew A Kanner, et al.
Scientific Reports
|
September 12, 2018
An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures
Grace Collord, Patrick Tarpey, Natalja Kurbatova, et al.
Cancer Letters
|
December 3, 2025
Updated clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang, Do-Hyun Nam, Zvi Ram, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Theranostics
|
July 21, 2018
Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins
Rachel Blau, Yana Epshtein, Evgeni Pisarevsky, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|
June 2, 2018
Reverting the molecular fingerprint of tumor dormancy as a therapeutic strategy for glioblastoma
Galia Tiram, Shiran Ferber, Paula Ofek, et al.
JAMA Oncology
|
February 3, 2018
Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma: A Secondary Analysis of a Randomized Clinical Trial
Martin J B Taphoorn, Linda Dirven, Andrew A Kanner, et al.
JAMA
|
December 21, 2017
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew Kanner, et al.
Molecular Cancer
|
August 10, 2023
Local delivery of hrBMP4 as an anticancer therapy in patients with recurrent glioblastoma: a first-in-human phase 1 dose escalation trial
Eelke M Bos, Elena Binda, Iris S C Verploegh, et al.
JAMA
|
December 17, 2015
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma: A Randomized Clinical Trial
Roger Stupp, Sophie Taillibert, Andrew A Kanner, et al.
Acta Neuropathologica
|
May 10, 2019
Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
Nagarajan Paramasivam, Daniel Hübschmann, Umut H Toprak, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 22, 2012
NovoTTF-100A versus physician's choice chemotherapy in recurrent glioblastoma: a randomised phase III trial of a novel treatment modality
Roger Stupp, Eric T Wong, Andrew A Kanner, et al.
Scientific Reports
|
September 12, 2018
An integrated genomic analysis of anaplastic meningioma identifies prognostic molecular signatures
Grace Collord, Patrick Tarpey, Natalja Kurbatova, et al.
Cancer Letters
|
December 3, 2025
Updated clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang, Do-Hyun Nam, Zvi Ram, et al.
Page
of 14